Clinical Trial Update: Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embryo Transfer Cycle [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for FB301 evaluating its effect on vaginal bacterial profile in women with asymptomatic vaginal dysbiosis undergoing a mock frozen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaginal Dysbiosis

Drugs mentioned

• FB301

Snippet

Sponsor: Freya Biosciences ApS | Conditions: Vaginal Dysbiosis | Phase 2 | Status: NOT_YET_RECRUITING